ArticlePharmaceuticals (Basel, Switzerland)2019

Biological Evaluation of Arylsemicarbazone Derivatives as Potential Anticancer Agents.

Anne Cecília Nascimento da Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.